|
1
|
Qipshidze N, Metreveli N, Mishra PK,
Lominadze D and Tyagi SC: Hydrogen sulfide mitigates cardiac
remodeling during myocardial infarction via improvement of
angiogenesis. Int J Biol Sci. 8:430–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuzun E, Bick R, Kadipasaoglu C, Conger
JL, Poindexter BJ, Gregoric ID, Frazier OH, Towbin JA and
Radovancevic B: Modification of a volume-overload heart failure
model to track myocardial remodeling and device-related reverse
remodeling. ISRN Cardiol. 2011:8310622011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wongcharoen W, Jai-Aue S, Phrommintikul A,
Nawarawong W, Woragidpoonpol S, Tepsuwan T, Sukonthasarn A, Apaijai
N and Chattipakorn N: Effects of curcuminoids on frequency of acute
myocardial infarction after coronary artery bypass grafting. Am J
Cardiol. 110:40–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS
and Kim SJ: Curcumin protects against regional myocardial
ischemia/reperfusion injury through activation of RISK/GSK-3β and
inhibition of p38 MAPK and JNK. J Cardiovasc Pharmacol Ther.
17:387–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang NP, Wang ZF, Tootle S, Philip T and
Zhao ZQ: Curcumin promotes cardiac repair and ameliorates cardiac
dysfunction following myocardial infarction. Br J Pharmacol.
167:1550–1562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sunagawa Y, Sono S, Katanassaka Y,
Funamoto M, Hirano S, Miyazaki Y, Hojo Y, Suzuki H, Morimoto E,
Marui A, et al: Optimal dose-setting study of curcumnin for
improvement of left ventricular systolic function after myocardial
infarction in rats. J Pharmacol Sci. 126:329–336. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv FH, Wang YL, Kong J, et al: Effects of
curcumin on expression of apoptosis-related genes in myocardial
cells of rats with acute myocardial infarction. J Appl Clin
Pediatr. 26:1010–1011. 2011.
|
|
8
|
Ng SC and Kamm MA: Therapeutic strategies
for the management of ulcerative colitis. Inflamm Bowel Dis.
15:935–950. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N, Tian Y, Wang C, Zhang P and You S:
Protective effect of Lai Fu Cheng Qi decoction on severe acute
pancreatitis-induced myocardial injury in a rat model. Exp Ther
Med. 9:1133–1140. 2015.PubMed/NCBI
|
|
10
|
Konstantinova EV, Khomyakova NF,
Konstantinova NA, Podkolzina AV and Sapozhnikov AM: Relationship
between apoptosis and expression of heat shock proteins in
peripheral blood lymphocytes of patients with myocardial
infarction. Bull Exp Biol Med. 150:682–684. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rondeau I, Picard S, Bah TM, Roy L,
Godbout R and Rousseau G: Effects of different dietary ω-6/3
polyunsaturated fatty acids ratios on infarct size and the limbic
system after myocardial infarction. Can J Physiol Pharmacol.
89:169–176. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee Y and Gustafsson AB: Role of apoptosis
in cardiovascular disease. Apoptosis. 4:536–548. 2009. View Article : Google Scholar
|
|
13
|
Wongcharoen W and Phrommintikul A: The
protective role of curcumin in cardiovascular diseases. Int J
Cardiol. 2:145–151. 2009. View Article : Google Scholar
|
|
14
|
Basnet P and Skalko-Basnet N: Curcumin: An
anti-inflammatory molecule from a curry spice on the path to cancer
treatment. Molecules. 16:4567–4598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han YK, Lee SH, Jeong HJ, Kim MS, Yoon MH
and Kim WM: Analgesic effects of intrathecal curcumin in the rat
formalin test. Korean J Pain. 25:1–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan HY, Kuang SY, Zheng X, Ling HY, Yang
YB, Yan PK, Li K and Liao DF: Curcumin inhibits cellular
cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling
pathway in vascular smooth muscle cells. Acta Pharmacol Sin.
29:555–563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
González-Salazar A, Molina-Jijón E, Correa
F, Zarco-Márquez G, Calderón-Oliver M, Tapia E, Zazueta C and
Pedraza-Chaverri J: Curcumin protects from cardiac reperfusion
damage by attenuation of oxidant stress and mitochondrial
dysfunction. Cardiovasc Toxicol. 11:357–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morimoto T, Sunagawa Y, Fujita M and
Hasegawa K: Novel heart failure therapy targeting transcriptional
pathway in cardiomyocytes by a natural compound, curcumin. Circ J.
74:1059–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wongcharoen W and Phrommintikul A: The
protective role of curcumin in cardiovascular diseases. Int J
Cardiol. 133:145–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kiefel H, Pfeifer M, Bondong S, Hazin J
and Altevogt P: Linking L1CAM-mediated signaling to NF-κB
activation. Trends Mol Med. 4:178–187. 2011. View Article : Google Scholar
|
|
22
|
Oeckinghaus A, Hayden MS and Ghosh S:
Crosstalk in NF-κB signaling pathways. Nat Immunol. 8:695–708.
2011. View
Article : Google Scholar
|
|
23
|
Sunagawa Y, Wada H, Suzuki H, Imaizumi A,
Fukuda H, Hashimoto T, Katanasaka Y, Shimatsu A, Kimura T, et al: A
novel drug delivery system of oral curcumin markedly improves
efficacy of treatment for heart failure after myocardial infarction
in rats. Biol Pharm Bull. 2:139–144. 2012. View Article : Google Scholar
|
|
24
|
Hisada S, Shimizu K, Shiratori K and
Kobayashi M: Peroxisome proliferator-activated receptor gamma
ligand prevents the development of chronic pancreatitis through
modulating NF-kappaB-dependent proinflammatory cytokine production
and pancreatic stellate cell activation. Rocz Akad Med Bialymst.
50:142–147. 2005.PubMed/NCBI
|
|
25
|
Ahmadian M, Suh J M, Hah N, Liddle C,
Atkins AR, Downes M and Evans RM: PPARγ signaling and metabolism:
The good, the bad and the future. Nat Med. 19:557–566. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv FH, Gao JZ and Zhang JY: Role of
peroxisome proliferator-activated receptor signaling pathway in
mice with hyperlipidemia. Chin J Geriatr. 30:1047–1050. 2011.
|
